Share-based Payment Arrangement, Expense of Bicara Therapeutics Inc. from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bicara Therapeutics Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2023 to 30 Sep 2025.
  • Bicara Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $3,614,000, a 78% increase year-over-year.
  • Bicara Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $13,738,000.
  • Bicara Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2024 was $7,397,000, a 290% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Bicara Therapeutics Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $13,738,000 $3,614,000 +$1,583,000 +78% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $12,155,000 $3,492,000 +$2,454,000 +236% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $9,701,000 $3,451,000 +$2,304,000 +201% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $7,397,000 $3,181,000 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $2,031,000 +$1,512,000 +291% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $1,038,000 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $1,147,000 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q3 2023 $519,000 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3

Bicara Therapeutics Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $7,397,000 +$5,498,000 +290% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $1,899,000 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.